Carisma Therapeutics Inc. Stock
Our community identified positive and negative aspects for Carisma Therapeutics Inc. stock for the coming years. 1 users see the criterium "EBIT growth" as a plus for the Carisma Therapeutics Inc. stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Carisma Therapeutics Inc. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Carisma Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Carisma Therapeutics Inc. | - | - | - | - | - | - | - |
| Ardelyx Inc. | -1.850% | 18.588% | 11.880% | 8.474% | 20.399% | 103.685% | 3.500% |
| Evolus Inc | -12.450% | 1.271% | -16.140% | -46.889% | -12.294% | -39.108% | 1.228% |
| Champions Oncology Inc | 4.460% | 2.752% | 8.738% | 17.647% | -3.448% | 40.704% | -37.430% |